Duncan McLaren

Search results

• 2023

  Redefining precision radiotherapy through liquid biopsy

  McLaren, D. & Aitman, T. J., 5 Oct 2023, In: British Journal of Cancer. 129, 6, p. 900-903

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liquid Biopsy 100%
  • Radiation Therapy 100%
  • Neoplasm 66%
  • Tissue Reaction 33%
  • Cell-Free DNA 33%

• Machine-learning with region-level radiomic and dosimetric features for predicting radiotherapy-induced rectal toxicities in prostate cancer patients

  Yang, Z., Noble, D. J., Shelley, L., Berger, T., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., Jun 2023, In: Radiotherapy and Oncology. 183, p. 109593 109593.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Prostate Cancer 100%
  • Radiomics 100%
  • Radiation Therapy 100%
  • Bleeding 42%
  • Computer Assisted Tomography 28%

• Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients

  Berger, T., Noble, D. J., Yang, Z., Shelley, L. E. A., McMullan, T., Bates, A., Thomas, S., Carruthers, L. J., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 21 Feb 2023, (E-pub ahead of print) In: Acta Oncologica. 62, 2, p. 166-173

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Parotid Gland 100%
  • Predictor 25%
  • Radiation Therapy 25%

• Assessing the generalisability of radiomics features previously identified as predictive of radiation-induced sticky saliva and xerostomia

  Berger, T., Noble, D. J., Yang, Z., Shelley, L. E. A., McMullan, T., Bates, A., Thomas, S., Carruthers, L. J., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., Jan 2023, In: Physics and Imaging in Radiation Oncology. 25, 100404.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Xerostomia 100%
  • Radiomics 100%
  • Radiation Therapy 100%
  • Head and Neck Cancer 50%
  • Salivary Gland 50%
• 2022

  Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features

  Berger, T., Noble, D. J., Shelley, L. E. A., McMullan, T., Bates, A., Thomas, S., Carruthers, L. J., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 4 Nov 2022, In: Physics and Imaging in Radiation Oncology. 24, p. 95-101 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Xerostomia 100%
  • Head and Neck Cancer 100%
  • Radiomics 100%
  • Radiation Therapy 100%
  • Neck 100%

• Peppermint protocol: first results for gas chromatography-ion mobility spectrometry

  Peppermint Consortium, Ruszkiewicz, D. M., Myers, R., Henderson, B., Yusof, H., Meister, A., Moreno, S., Eddleston, M., Darnley, K., Nailon, W. H., Mclaren, D., Lao, Y. E., Hovda, K. E., Lam, S., Cristescu, S. M. & Thomas, C. L. P., 26 May 2022, In: Journal of Breath Research.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Peppermint 100%
  • Gas Chromatography 100%
  • Peppermint Oil 50%
  • Cineole 50%
  • Pinene 25%

• Fast and automated biomarker detection in breath samples with machine learning

  Skarysz, A., Salman, D., Eddleston, M., Sykora, M., Hunsicker, E., Nailon, W. H., Darnley, K., McLaren, D., Thomas, C. L. P. & Soltoggio, A., 12 Apr 2022, In: PLoS ONE.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Learning System 100%
  • Breathing 100%
  • Gas Chromatography Mass Spectrometry 100%
  • Neural Network 66%
  • Gas Chromatography-Mass Spectrometry 66%
• 2021

  50 years of radiotherapy research: evolution, trends and lessons for the future

  Berger, T., Noble, D. J., Shelley, L. E. A., Hopkins, K. I., McLaren, D. B., Burnet, N. G. & Nailon, W. H., Dec 2021, In: Radiotherapy & Oncology. 165, p. 75-86

  Research output: Contribution to journal › Review article › peer-review

  • Radiation Therapy 100%
  • Radiation Oncology 50%
  • Malignant Neoplasm 16%
  • Cancer Therapy 16%
  • Cancer Radiotherapy 16%

• Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival

  Noble, D. J., Doyle, E., Tramonti, G., Law, A. B., Sundaramurthy, A., Brush, J. P., Keanie, J., Wood, C., Drewell, P., Keough, W. & Mclaren, D. B., 28 Nov 2021, In: Clinical Oncology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

  Meehan, J., Gray, M., Martinez-Perez, C., Kay, C., McLaren, D. & Turnbull, A. K., 15 Jul 2021, (E-pub ahead of print) In: Journal of personalized medicine.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Biological Marker 100%
  • Prostate Cancer 100%
  • Personalized Medicine 100%
  • Prostate-Specific Antigen 100%
  • Prostate Specific Antigen 100%

• Localised 3D disparity regularisation for improving contour propagation in Adaptive Radiotherapy

  Pannir Selvam, D. A., Laurenson, D. I., Nailon, B. & McLaren, D., 15 Feb 2021. 12 p.

  Research output: Contribution to conference › Poster › peer-review

  • Dice Similarity Score 100%
  • Orientation Vector 100%
  • Neighboring Motion Vector 100%

• PO-1584: Predicting xerostomia in head and neck cancer using imaging biomarkers from daily tomotherapy MVCTs

  Berger, T., Noble, D. J., Shelley, L. E., McMullan, T., Romanchikova, M., Carruthers, L. J., Cebamanos, L., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 5 Feb 2021, (E-pub ahead of print) p. S859-S860.

  Research output: Contribution to conference › Poster › peer-review

• PO-1585: Subregional analysis of the parotid glands: predicting late xerostomia in head and neck cancer

  Berger, T., Noble, D. J., Shelley, L. E., McMullan, T., Romanchikova, M., Carruthers, L. J., Cebamanos, L., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 5 Feb 2021, (E-pub ahead of print) p. S860-S861.

  Research output: Contribution to conference › Poster › peer-review
• 2020

  Predicting late xerostomia in head and neck cancer patients from imaging biomarkers calculated on daily TomoTherapy MVCT images

  Berger, T., Noble, D. J., Shelley, L. E., McMullan, T., Romanchikova, M., Carruthers, L. J., Cebamanos, L., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 26 Nov 2020, (E-pub ahead of print) In: Radiotherapy & Oncology. 152, Supplement 1, p. S859-S860

  Research output: Contribution to journal › Meeting abstract › peer-review

  • Neck 100%
  • Electric Potential 100%
  • Xerostomia 100%
  • X-Ray Computed Tomography 33%
  • Parotid Gland 33%

• Sub-regional analysis of the parotid glands: predicting late xerostomia with imaging biomarkers in head and neck cancer patients

  Berger, T., Noble, D. J., Shelley, L. E., McMullan, T., Romanchikova, M., Carruthers, L. J., Cebamanos, L., Beckett, G., Duffton, A., Paterson, C., Jena, R., McLaren, D. B., Burnet, N. G. & Nailon, W. H., 26 Nov 2020, (E-pub ahead of print) In: Radiotherapy & Oncology. 152, Supplement 1, p. S860-S861 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

  • Biological Marker 100%
  • Xerostomia 100%
  • Head and Neck Cancer 100%
  • Parotid Gland 100%
  • Stem Cell 100%

• Analysis of the Intra-Fractional Motion of the Prostate During SBRT Using an EM Transmitter

  Trainer, M., Carruthers, L., McLaren, D., Nailon, B. & Kirby, M., 1 Nov 2020, In: International Journal of Radiation Oncology - Biology - Physics. 108, 3, Supplement, p. e340 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Breath markers for therapuetic radiation

  Salman, D., Eddleston, M., Darnley, K., Nailon, W., Mclaren, D., Hadjithekli, A., Ruszkiewicz, D. M., Langejuergen, J., Alkhalifah, Y., Phillips, I. & Thomas, C. L. P., 21 Jul 2020, (E-pub ahead of print) In: Journal of Breath Research.

  Research output: Contribution to journal › Article › peer-review

  Open Access
• 2019

  VOCCluster: Untargeted Metabolomics Feature Clustering Approach for Clinical Breath Gas Chromatography - Mass Spectrometry Data

  Alkhalifah, Y., Phillips, I., Soltoggio, A., Darnley, K., Nailon, W. H., Mclaren, D., Eddleston, M., Thomas, C. L. P. & Salman, D., 2 Dec 2019, (E-pub ahead of print) In: Analytical Chemistry.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• A deep learning approach for identifying focal prostate cancer from multi-parametric MRI

  Rooney, M., Killean, A., Mitchell, J., McLaren, D. & Nailon, B., 1 Apr 2019, In: Radiotherapy & Oncology. 133, 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Applying the Linear Quadratic Model to PC-3 cells irradiated under different O2 conditions

  McMullan, T., Meehan, J., Langdon, S. P., McLaren, D., McLaughlin, S. & Nailon, B., 1 Apr 2019, In: Radiotherapy & Oncology. 133

  Research output: Contribution to journal › Meeting abstract › peer-review

• Development of a deep learning network using a pre-trained convolutional neural network

  Rooney, M., McLaren, D., Nailon, B. & Mitchell, J., 1 Apr 2019, In: Radiotherapy & Oncology. 133, 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• VOCCluster: Untargeted Metabolomics Feature Clustering Approach for Clinical Breath Gas Chromatography-Mass Spectroscopy Data

  Alkhalifah, Y., Phillips, I., Soltoggio, A., Darnley, K., Nailon, W. H., McLaren, D., Eddleston, M., Thomas, P. & Salman, D., 18 Feb 2019, (ChemRxiv).

  Research output: Working paper

• Radiological Response Heterogeneity is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

  Hall, P. E., Shepherd, S. T. C., Brown, J., Larkin, J., Jones, R., Ralph, C., Hawkins, R., Chowdhury, S., Boleti, E., Bahl, A., Fife, K., Webb, A., Crabb, S. J., Geldart, T., Hill, R., Dunlop, J., McLaren, D., Ackerman, C., Wimalasingham, A., Beltran, L., & 2 othersNathan, P. & Powles, T., 9 Feb 2019, (E-pub ahead of print) In: European Urology Focus.

  Research output: Contribution to journal › Article › peer-review

  • Diseases 100%
  • Vasculotropin 100%
  • Cancer Staging 100%
  • Renal Cell Carcinoma 100%
  • Kidney Metastasis 100%

• Evaluating the Safety of Up-front Docetaxel in the Treatment of Metastatic and Locally Advanced Prostate Cancer

  Killean, A., Law, A., Malik, J., Sundaramurthy, A. & McLaren, D., Feb 2019, In: Clinical Oncology. 31, 2, p. E21-E23 5 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• EPID-based in-vivo dosimetry using Dosimetry Check™: overview and clinical experience in a five year study including breast, lung, prostate and head and neck cancer patients

  Nailon, W. H., Welsh, D., McDonald, K., Burns, D., Forsyth, J., Cooke, G., Cutanda, F., Carruthers, L. J., McLaren, D. B., Puxeu Vaqué, J., Kehoe, T. & Andiappa, S., 15 Jan 2019, In: Journal of Applied Clinical Medical Physics. 20, 1, p. 6-16 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Lung 100%
  • Head and Neck Cancer 100%
  • Dosimetry 100%
  • in Vivo Dosimetry 100%
  • Electronic Portal Imaging Device 100%
• 2018

  Addition of docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): modelling to estimate long-term survival, quality-adjusted survival and cost benefit

  Woods, B. S., Sideris, E., Sydes, M. R., Gannon, M., Parmar, M. KB., Alzouebi, M., Attard, G., Birtle, A. J., Brock, S., Cathomas, R., Chakraborti, P. R., Cook, A., Cross, W. R., Dearnaley, D. P., Gibbs, S., Graham, J. D., Gale, J., hughes, R., Jones, R., Laing, R., & 24 othersMason, M. D., McLaren, D., Matheson, D., Millman, R., O’Sullivan, J., Parikh, O., Parker, C., Peedell, C., Protheroe, A., Ritchie, A. WS., Robinson, A. J., Russell, M., Simms, M. S., Srihari, N. N., Srinivasan, R., Staffurth, J., Sundar, S., Thalmann, G. N., Tolan, S., Tran, A. TH., Tsang, D., Wagstaff, J., James, N. D. & Sculpher, M. J., 1 Dec 2018, In: European Urology Oncology. 1, 6, p. 449-458 9 p.

  Research output: Contribution to journal › Article › peer-review

• A Clinical Decision Support Tool Based on Active Appearance Modelling for Prostate Segmentation

  Cheng, K., Li, H., McLaren, D., McLaughlin, S. & Nailon, W., 18 Jun 2018, In: Radiotherapy & Oncology. 127, p. S550-S551

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access

• Automatic Segmentation of the Prostate Using Shape Models

  Ding, T., McLaren, D. B. & Nailon, W., 18 Jun 2018, In: Radiotherapy & Oncology. 127, p. S1175

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: Directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

  The STAMPEDE Investigators, 1 May 2018, In: Annals of Oncology. 29, 5, p. 1235-1248 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Prostate Cancer 100%
  • Arm 100%
  • Hormone Therapy 100%
  • Abiraterone 100%
  • Prednisolone 100%

• Convolutional neural networks for automated targeted analysis of raw gas chromatography-mass spectrometry data

  Skyarysz, A., Alkhalifah, Y., Darnley, K., Eddleston, M., McLaren, D., Nailon, W. H., Salman, D., Sykora, M., Thomas, P. & Soltoggio, A., May 2018, Proceedings of theInternational Joint Conference on Neural Networks (IJCNN 2018)At: Rio de Janeiro, Brazil.

  Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  Open Access

  • Gas Chromatography Mass Spectrometry 100%
  • Neural Network 100%
  • Volatile Organic Compound 75%
  • Learning System 40%
  • Support Vector Machine 20%

• TCP modelling of a hypoxic subvolume within the prostate

  McMullan, T. J., McLaren, D. B. & Nailon, W. H., 2018, In: Radiotherapy & Oncology. 127, p. S1269-S1270 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access
• 2017

  A core outcome set for localised prostate cancer effectiveness trials

  the COMPACTERS Study Group, 1 Nov 2017, In: BJU International. 120, 5, p. E64-E79

  Research output: Contribution to journal › Article › peer-review

  • Prostate Cancer 100%
  • Hormone Therapy 25%
  • Recurrent Disease 25%
  • Clinical Trial 12%
  • Disease Exacerbation 12%

• Clinical and patient-reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

  Huddart, R. A., Birtle, A., Maynard, L., Beresford, M., Blazeby, J., Donovan, J., Kelly, J. D., Kirkbank, T., McLaren, D. B., Mead, G., Moynihan, C., Persad, R., Scrase, C., Lewis, R. & Hall, E., 1 Nov 2017, In: BJU International. 120, 5, p. 639-650 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Bladder 100%
  • Patient-Reported Outcome 100%
  • Cystectomy 100%
  • Neoadjuvant Chemotherapy 50%
  • Radiation Therapy 33%

• Automatic delineation of the gross-tumour volume in prostate cancer using shape models

  Cheng, K., Feng, Y., Montgomery, D., McLaren, D., McLaughlin, S. & Nailon, W. H., 1 May 2017, In: Radiotherapy & Oncology. 123, p. S940 EP-1714.

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access

• In-vivo dosimetry using Dosimetry Check: 5-year experience on 345 prostate cancer patients

  Nailon, W. H., Welsh, D., MacDonald, K., Burns, D., Forsyth, J., Cooke, G., Cutanda, F., McLaren, D., Puxeu-Vaqué, J., Kehoe, T. & Andiappa, S., 1 May 2017, In: Radiotherapy & Oncology. 123, p. S777 1 p., EP-1456.

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access

• Predicting radiation-induced pneumonitis in NSCLC: a radiobiological and texture analysis study

  Nailon, W., Lu, W., Montgomery, D., Carruthers, L., Murchiston, J., Yong, AW., Ritchie, G., Evans, T., Little, F., Erridge, SC., McLaren, D. & Campbell, S., 1 May 2017, In: Radiotherapy & Oncology. 123, p. S947 1 p., EP-1725.

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access

• Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)

  Andronis, L., Goranitis, I., Pirrie, S., Pope, A., Barton, D., Collins, S., Daunton, A., McLaren, D., O'Sullivan, J. M., Parker, C., Porfiri, E., Staffurth, J., Stanley, A., Wylie, J., Beesley, S., Birtle, A., Brown, J. E., Chakraborti, P., Hussain, S. A., Russell, J. M., & 2 othersBillingham, L. J. & James, N. D., 1 Apr 2017, In: BJU International. 119, 4, p. 522-529 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Chemotherapy 100%
  • Prostate Cancer 100%
  • Zoledronic Acid 100%
  • Strontium 89 100%
  • Health Status 8%

• Identifying the dominant prostate cancer focal lesion using 3D image texture analysis

  Montgomery, D., Cheng, K., Feng, Y., McLaren, DB., McLaughlin, S. & Nailon, W., 2017, In: Radiotherapy & Oncology. 123, p. S498-S499

  Research output: Contribution to journal › Meeting abstract › peer-review

  Open Access
• 2016

  Correction: Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors

  Camus, V. L., Stewart, G. D., Nailon, W. H., McLaren, D. B. & Campbell, C. J., 13 Sept 2016, (E-pub ahead of print) In: Analyst. 141, 20, p. 5900-5900 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Targeted SERS nanosensors measure physicochemical gradients and free energy changes in live 3D tumor spheroids

  Jamieson, L. E., Camus, V. L., Bagnaninchi, P. O., Fisher, K. M., Stewart, G. D., Nailon, W. H., McLaren, D. B., Harrison, D. J. & Campbell, C. J., 6 Sept 2016, In: Nanoscale. 8, 37, p. 16710-16718 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Tumor Spheroid 100%
  • Surface-Enhanced Raman Spectroscopy 100%
  • Nanosensor 100%
  • In Vitro 100%
  • Drug Resistance 100%

• TRAPEZE: A randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer

  James, N., Pirrie, S., Pope, A., Barton, D., Andronis, L., Goranitis, I., Collins, S., McLaren, D., O’Sullivan, J., Parker, C., Porfiri, E., Staffurth, J., Stanley, A., Wylie, J., Beesley, S., Birtle, A., Brown, J., Chakraborti, P., Russell, M. & Billingham, L., 1 Jul 2016, In: Health Technology Assessment. 20, 53, p. 1-127 127 p.

  Research output: Contribution to journal › Article › peer-review

  • Randomized Controlled Trial 100%
  • Prostate Cancer 100%
  • Cost-Effectiveness Analysis 100%
  • Zoledronic Acid 100%
  • Strontium 89 100%

• Measuring the effects of fractionated radiation therapy in a 3D prostate cancer model system using SERS nanosensors

  Camus, V. L., Stewart, G., Nailon, W. H., Mclaren, D. B. & Campbell, C. J., 16 Jun 2016, In: Analyst. p. 5056-5061 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Model System 100%
  • Nanosensors 100%
  • Radiotherapy 100%
  • Neoplasm 100%
  • Prostate Cancer 100%

• A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)

  Powles, T., Brown, J., Larkin, J., Jones, R., Ralph, C., Hawkins, R., Chowdhury, S., Boleti, E., Bhal, A., Fife, K., Webb, A., Crabb, S., Geldart, T., Hill, R., Dunlop, J., Hall, P. E., McLaren, D., Ackerman, C., Beltran, L. & Nathan, P., 1 May 2016, In: Annals of Oncology. 27, 5, p. 880-886 7 p., mdw014.

  Research output: Contribution to journal › Article › peer-review

  • Kidney Cancer 100%
  • Saracatinib 100%
  • Cediranib 100%
  • Biological Marker 66%
  • Progression Free Survival 66%

• Can Glomerular Filtration Rate by Wright Formula Replace Technetium-99m Labelled Glomerular Filtration Rate in Patients Receiving Adjuvant Carboplatin for Stage I Seminoma

  Sundaramurthy, A., Malik, J., McLaren, D. & Law, A., May 2016, In: Clinical Oncology. 28, 5, p. E16-E16 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Clinical outcomes and survival following treatment of metastatic castrate-refractory prostate cancer with docetaxel alone or with strontium-89, zoledronic acid, or both: The TRAPEZE randomized clinical trial

  James, N. D., Pirrie, S. J., Pope, A. M., Barton, D., Andronis, L., Goranitis, I., Collins, S., Daunton, A., McLaren, D., O'Sullivan, J., Parker, C., Porfiri, E., Staffurth, J., Stanley, A., Wylie, J., Beesley, S., Birtle, A., Brown, J., Chakraborti, P., Hussain, S., & 2 othersRussell, M. & Billingham, L. J., 1 Apr 2016, In: JAMA Oncology. 2, 4, p. 493-499 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Randomized Clinical Trial 100%
  • Prostate Cancer 100%
  • Docetaxel 100%
  • Zoledronic Acid 100%
  • Strontium 89 100%

• Using texture analysis to detect prostate cancer for automated outlining and adaptive radiotherapy

  Welsh, D., Montgomery, D., McLaren, D. & Nailon, W. H., 1 Apr 2016, In: Radiotherapy & Oncology. 119, p. s31 oc-0069.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

  James, N. D., Sydes, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Spears, M. R., Ritchie, A. W. S., Parker, C. C., Russell, J. M., Attard, G., De Bono, J., Cross, W., Jones, R. J., Thalmann, G., Amos, C., Matheson, D., Millman, R., Alzouebi, M., Beesley, S., Birtle, A. J., & 27 othersBrock, S., Cathomas, R., Chakraborti, P., Chowdhury, S., Cook, A., Elliott, T., Gale, J., Gibbs, S., Graham, J. D., Hetherington, J., Hughes, R., Laing, R., McKinna, F., McLaren, D. B., O'Sullivan, J. M., Parikh, O., Peedell, C., Protheroe, A., Robinson, A. J., Srihari, N., Srinivasan, R., Staffurth, J., Sundar, S., Tolan, S., Tsang, D., Wagstaff, J. & Parmar, M. K. B., 19 Mar 2016, In: The Lancet. 387, 10024, p. 1163-1177 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Randomized Controlled Trial 100%
  • Prostate Cancer 100%
  • Hormone Therapy 100%
  • Zoledronic Acid 100%
  • Docetaxel 100%

• INVITED REVIEW-IMAGE REGISTRATION IN VETERINARY RADIATION ONCOLOGY: INDICATIONS, IMPLICATIONS, AND FUTURE ADVANCES

  Feng, Y., Lawrence, J., Cheng, K., Montgomery, D., Forrest, L., Mclaren, D. B., McLaughlin, S., Argyle, D. J. & Nailon, W. H., 18 Jan 2016, In: Veterinary Radiology & Ultrasound. 57, 2, p. 113-123 10 p.

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  File

  • Neoplasm 100%
  • Veterinary Medicine 33%
  • Veterinary Oncology 33%
  • Comparative Oncology 33%
  • Magnetic Resonance Imaging 33%

• Hardware accelerated image processing to enable real-time adaptive radiotherapy

  Robinson, F., Crockett, L., Nailon, B., Stewart, B. & McLaren, D., 2016.

  Research output: Contribution to conference › Poster

• Hardware accelerated segmentation of CT images for adaptive radiotherapy

  Robinson, F., Crockett, L., Nailon, B., Stewart, B. & McLaren, D., 2016.

  Research output: Contribution to conference › Abstract › peer-review